ImmuneRegen BioSciences, Inc. (IRBO) Reports Positive Results in Cancer Vaccine Studies in Radboud University Nijmegen Medical Centre Collaboration
10/28/2010 11:24:35 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)
9/8/2010 11:19:49 AM
More...
|
Scancell Release: Collaboration With ImmuneRegen BioSciences, Inc. (IRBO) Yields Positive Results in Cancer Vaccine Studies
9/7/2010 9:04:13 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Invited to Submit Full Proposal to Biomedical Advanced Research and Development Authority (BARDA) for Homspera(R) as a Potential Medical Countermeasure for Injury Associated With Radiation Exposure
8/31/2010 1:37:37 PM
More...
|
University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen BioSciences, Inc. (IRBO)'s Homspera(R)
8/25/2010 8:23:56 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Completes Successful Reduction of Debt
8/4/2010 10:59:17 AM
More...
|
Scancell Enters Strategic Collaboration with ImmuneRegen BioSciences, Inc. (IRBO)(R)
6/4/2010 9:46:09 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Medical Centre, the Netherlands
4/27/2010 10:58:57 AM
More...
|
NeoStem, Inc. and ImmuneRegen BioSciences, Inc. (IRBO) to Collaborate on Stem Cells
4/23/2010 1:59:32 PM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indications
4/21/2010 11:47:20 AM
More...
|
|